Ascertainment of Saliva or Blood Samples For Genetic Epidemiology Studies of Cancer and Aging

NCT ID: NCT00579618

Last Updated: 2017-07-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

53 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-09-30

Study Completion Date

2017-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to help us learn more about the roles of genes in cancers. Genes are short pieces of DNA which determine the inherited characteristics that distinguish one individual from another. This study will look at how some genes might raise or lower the chance some people may develop cancer. The sample collection will help generate the materials needed for this study.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a protocol to obtain saliva or blood samples from non-cancer affected volunteers aged 60 years or older, without a history of cancer other than non-melanoma skin cancer. These samples will be used in a genomic approach to elucidate novel pathways of cancer predisposition.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-cancer Affected Volunteers

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Saliva or Blood samples

Extracting sample of saliva or blood only once.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Eligible subjects must be non-cancer affected volunteers of either gender who are 60 years of age or older at the time of saliva/blood donation.
* Subjects will self-identify religion and country of origin of grandparents.
* Volunteers will have (by self report) no history of cancer other than nonmelanoma skin cancer. It is recognized that there may be some errors in self report, however, the literature reports a very low error rate for self reported disease reporting for cancer as assessed by interview.

Exclusion Criteria

* Subjects with mental impairment will be excluded from this study.
Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Susan G. Komen Breast Cancer Foundation

OTHER

Sponsor Role collaborator

Beth Abraham

UNKNOWN

Sponsor Role collaborator

Gurwin Jewish Nursing & Rehabilitation Center

OTHER

Sponsor Role collaborator

Hebrew Home at Riverdale

OTHER

Sponsor Role collaborator

Jewish Home & Hospital Lifecare System

OTHER

Sponsor Role collaborator

Margaret Tietz Nursing and Rehabilitation Center

OTHER

Sponsor Role collaborator

Metropolitan Jewish Health System

OTHER

Sponsor Role collaborator

Northern Services Group

UNKNOWN

Sponsor Role collaborator

Parker Jewish Institute

UNKNOWN

Sponsor Role collaborator

Lenox Hill Neighborhood House

OTHER

Sponsor Role collaborator

JASA at Temple Emanuel of Parkchester Senior Center

UNKNOWN

Sponsor Role collaborator

Van Cortlandt Village Senior Center

OTHER

Sponsor Role collaborator

Memorial Sloan Kettering Cancer Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kenneth Offit, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Memorial Sloan Kettering Cancer Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

http://www.mskcc.org

Memorial Sloan Kettering Web Site

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

06-102

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Clinical Significance of Germline BRCA Mutations
NCT00579488 ACTIVE_NOT_RECRUITING